Prof. Dr. Anna L. David is Professor in Obstetrics and Maternal Fetal Medicine and Director at the Elizabeth Garrett Anderson Institute for Women’s Health, University College London (UCL). She was appointed as the first recipient of The Professor Tan Seang Lin, Dr Grace Tan and OriginElle Fertility Distinguished Chair in Women’s Health at UCL in January 2025. She is Consultant in Obstetrics and Maternal Fetal Medicine at University College London Hospitals (UCLH), London, UK. She is also Visiting Professor of Fetal Medicine at KU (Katholieke Universiteit) Leuven, Belgium. She trained in medicine and qualified from St Andrew’s University, Scotland in 1989 with a first class Intercalated BSc in Medical Science and from Manchester University in 1992 when she was awarded MB ChB. She undertook specialty training in obstetrics and gynaecology in London (NW Thames London Deanery). She completed a PhD on fetal gene therapy in 2005, and then undertook subspecialty training in maternal fetal medicine at UCL with Professor Charles Rodeck as supervisor, becoming a consultant in 2008. She was awarded an NIHR Clinical Senior Lectureship in Women’s Health in 2008 and was promoted to Professor in 2016. She became Head of Research Department for Maternal Fetal Medicine in 2016 and Director of the EGA Institute for Women's Health in 2018.
Prof. Dr. Anna L. David is Professor in Obstetrics and Maternal Fetal Medicine and Director at the Elizabeth Garrett Anderson Institute for Women’s Health, University College London (UCL). She was appointed as the first recipient of The Professor Tan Seang Lin, Dr Grace Tan and OriginElle Fertility Distinguished Chair in Women’s Health at UCL in January 2025. She is Consultant in Obstetrics and Maternal Fetal Medicine at University College London Hospitals (UCLH), London, UK. She is also Visiting Professor of Fetal Medicine at KU (Katholieke Universiteit) Leuven, Belgium. She trained in medicine and qualified from St Andrew’s University, Scotland in 1989 with a first class Intercalated BSc in Medical Science and from Manchester University in 1992 when she was awarded MB ChB. She undertook specialty training in obstetrics and gynaecology in London (NW Thames London Deanery). She completed a PhD on fetal gene therapy in 2005, and then undertook subspecialty training in maternal fetal medicine at UCL with Professor Charles Rodeck as supervisor, becoming a consultant in 2008. She was awarded an NIHR Clinical Senior Lectureship in Women’s Health in 2008 and was promoted to Professor in 2016. She became Head of Research Department for Maternal Fetal Medicine in 2016 and Director of the EGA Institute for Women's Health in 2018.